What is the MUSIC study?

The MUSIC study is an observational study where participants are followed up closely every 3 months for a year.

During this follow-up period, extra blood and stool samples are taken for scientific analyses. Participants will also be offered an extra colonoscopy to check for mucosal healing.

We hope that this study will unlock new scientific insights into inflammatory bowel disease.

Why Take Part?

  • MUSIC runs in conjunction with your existing NHS treatment. It simply aims to monitor you much more closely as your condition hopefully improves.
  • It will be a learning opportunity for you. The more involved you are with your treatment, the more you will learn about your condition and how you can get back to full health as soon as possible.
  • You will be contributing to the latest research, the long term goal of which is to find more effective treatments and ultimately a cure for IBD.

Who Can Take Part?

We are looking for patients:

  • Age 16 and above
  • Have Crohn's disease or ulcerative colitis
  • Referred by their NHS doctor
  • Edinburgh, Glasgow or Dundee

What is Involved?

This is a 12-month follow-up study which will involve appointments at 3 monthly intervals. We plan to closely monitor your clinical progress in line with the scientific work which we will carry out.

During the follow-up period, we will be gathering information on how you are doing and this information will be shared with your treating NHS clinician.

This may allow them to make treatment adjustments and check on how you're doing more closely than usual. For full details, please read the patient information sheet below.

  1. 0

    Start

  2. 3

    3 Months

  3. 6

    6 Months

  4. 9

    9 Months

  5. 12

    12 Months

Participating Centres

name

Edinburgh

Western General Hospital

Principal Investigator(s)

Dr Gwo-Tzer Ho

name

Glasgow

Queen Elizabeth University Hospital

Principal Investigator(s)

Dr John Paul Seenan & Dr Jonathan MacDonald

name

Dundee

Ninewells Hospital

Principal Investigator(s)

Dr Craig Mowat